13Jun 2023
Faropenem Promising Antituberculosis Candidate Competing With Ethambutol In Efficacy

Faropenem Promising Antituberculosis Candidate Competing With Ethambutol In Efficacy

A recent study published in the International Journal of Infectious Diseases suggests that Faropenem (FARPENAm) may be an effective alternative to ethambutol for treating tuberculosis (TB). The study in China involved newly diagnosed patients with drug-susceptible pulmonary TB. The experimental group replaced ethambutol with Faropenem for the first two months of treatment, while the control group followed the standard 6-month regimen. The study found that Faropenem showed comparable treatment success rates after six months compared to the control group. The Faropenem group experienced significantly fewer adverse events than the control group. These findings indicate that Faropenem could be a promising option for TB treatment, offering similar efficacy with fewer side effects.

  • #family health

Like

Save

Share